共 12 条
[2]
Transferable resistance to cefotaxime , cefoxitin , cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Knothe H,Shah P,Kremery V et al. Infection and Immunity . 1983
[3]
Negative regulation ofthe Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Ochs MM,McCusker MP,Bains M,et al. Antimicrobial Agents and Chemotherapy . 1999
[4]
Comparative studies of penicillin binding proteinsinc and Escherichi a coli. oguchi H,Matsuhashi M,and Mitsuhashi S. European Journal of Biochemistry . 1979
[5]
Prevention of drug access to bacterial targets :permeability barriers and active efflux. Nikaido H. Science . 1994
[6]
Transferable imipenem resistance in Pseudomonas areuginosa. Watanabe M,Lyobe S,Inoue M,et al. Antimicrobial Agents and Chemotherapy . 1991
[7]
More extended-spectrum beta-lactamases. Jacoby GA,Medeiros AA. Antimicrobial Agents and Chemotherapy . 1991
[8]
Beta2lactamases inhibitors aresubstrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Li XZ,Zhang L,Srilumar R,et al. Antimicrobial Agents and Chemotherapy . 1998
[9]
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens[J] . H. Knothe,P. Shah,V. Krcmery,M. Antal,S. Mitsuhashi.  Infection . 1983 (6)
[10]
Overexp ression of t he mexC- mexD-op rJ efflux operon in nfxB- type multidrug-resistant strains of Pseu domonas aeruginosa. Poole K,Gotoh N,Tsujimoto H,et al. Molecular Microbiology . 1996